Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases
- PMID: 32219857
- PMCID: PMC7228260
- DOI: 10.1111/ajd.13295
Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases
Comment in
-
Dermatology patients' knowledge and concerns regarding their immunomodulatory medication during the COVID-19 pandemic.Dermatol Ther. 2020 Jul;33(4):e13488. doi: 10.1111/dth.13488. Epub 2020 Jul 1. Dermatol Ther. 2020. PMID: 32356601 Free PMC article. No abstract available.
References
-
- Rademaker M, Agnew K, Andrews M et al. Managing atopic dermatitis with systemic therapies in adults and adolescents: An Australian/New Zealand narrative. Australas. J. Dermatol. 2020; 61: 9–22. - PubMed
-
- Rademaker M, Agnew K, Anagnostou N et al. Psoriasis and infection. A clinical practice narrative. Australas. J. Dermatol. 2019; 60: 91–8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
